Axial Therapeutics, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as Axial Biotherapeutics, Inc. (to 2021)
Recorded as renamed to Vertero Therapeutics, Inc. (2026)
0
Ending by 2030
Mar 2038
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Mar 5, 2027The maintenance fee for Inhibitors of Microbially Induced Amyloid (US 11,744,820) comes due Mar 5, 2027. Unpaid by Sep 7, 2027, it lapses early.
- 1 fee due Jul 30, 2027The maintenance fee for Sustained release solid dosage forms for modulating the colonic microbiome (US 11,883,537) comes due Jul 30, 2027. Unpaid by Jan 31, 2028, it lapses early.
- 2 fees due Oct 9 to 14, 2027 · next Oct 9
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 6 of 6
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,617,718 | Gut-selective sequestering agents for the treatment and prevention of autism and related disorders In force · USPTO record | In force | USPTO record | |
| US 11,147,792 | Inhibitors of Microbially Induced Amyloid In force · High confidence | In force | High confidence | |
| US 11,744,820 | Inhibitors of Microbially Induced Amyloid In force · High confidence | In force | High confidence | |
| US 11,505,528 | Inhibitors of microbially induced amyloid In force · USPTO record | In force | USPTO record | |
| US 11,883,537 | Sustained release solid dosage forms for modulating the colonic microbiome In force · USPTO record | In force | USPTO record | |
| US 11,951,094 | TLR2 modulator compounds, pharmaceutical compositions and uses thereof In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 6: 2 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 abandoned · 4 no status recorded